The Targeted Pulse: Good News for Advanced CLL/SLL With BGB-16673 Receiving Fast Track Designation and Sonrotoclax Plus ...
Want to test your knowledge on the latest oncology news? Check out this week’s quiz! BGB-16673 has received fast-track designation from the FDA for the treatment of patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) or small …